PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS — Credit Rating and Financial Key Figures
CVR number: 33242840
Sankt Ols Gade 4, 4000 Roskilde
tel: 46302030
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 26 958.41 | 34 797.07 | 44 685.54 | 55 810.25 | 64 001.72 |
| Employee benefit expenses | -24 866.19 | -32 152.29 | -40 699.61 | -52 232.04 | -59 944.89 |
| Total depreciation | -42.98 | -22.50 | -46.76 | -54.56 | -48.91 |
| EBIT | 2 049.24 | 2 622.29 | 3 939.17 | 3 523.64 | 4 007.92 |
| Other financial income | 2.89 | 39.38 | 17.05 | 52.64 | |
| Other financial expenses | -21.27 | -24.62 | -93.47 | -47.34 | -58.37 |
| Pre-tax profit | 2 030.86 | 2 637.04 | 3 845.70 | 3 493.35 | 4 002.19 |
| Income taxes | - 446.78 | - 580.15 | - 846.05 | - 770.13 | - 888.06 |
| Net earnings | 1 584.07 | 2 056.89 | 2 999.65 | 2 723.22 | 3 114.12 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 30.50 | 19.78 | 118.31 | 63.74 | 14.83 |
| Tangible assets total | 30.50 | 19.78 | 118.31 | 63.74 | 14.83 |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 360.78 | 695.91 | |||
| Current amounts owed by group member comp. | 8 756.67 | 12 608.71 | 16 851.51 | 15 026.11 | 37 445.44 |
| Prepayments and accrued income | 106.53 | 27.03 | 45.42 | 57.21 | |
| Current other receivables | 65.17 | 42.55 | 35.73 | ||
| Current deferred tax assets | 11.84 | 11.51 | 9.84 | 12.88 | 16.91 |
| Short term receivables total | 9 235.83 | 13 343.16 | 16 971.94 | 15 138.75 | 37 498.07 |
| Cash and bank deposits | 862.30 | 608.13 | 539.25 | 3 195.45 | 1 520.73 |
| Cash and cash equivalents | 862.30 | 608.13 | 539.25 | 3 195.45 | 1 520.73 |
| Balance sheet total (assets) | 10 128.63 | 13 971.07 | 17 629.50 | 18 397.95 | 39 033.63 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Retained earnings | 4 780.06 | 6 364.14 | 8 421.03 | 11 420.67 | 14 143.90 |
| Profit of the financial year | 1 584.07 | 2 056.89 | 2 999.65 | 2 723.22 | 3 114.12 |
| Shareholders equity total | 6 444.14 | 8 501.03 | 11 500.68 | 14 223.90 | 17 338.02 |
| Non-current other liabilities | 950.34 | 2 793.09 | 2 824.51 | ||
| Non-current liabilities total | 950.34 | 2 793.09 | 2 824.51 | ||
| Current trade creditors | 42.58 | 139.02 | 56.78 | ||
| Current owed to group member | 222.52 | 769.13 | 834.57 | 792.87 | 17 354.18 |
| Short-term deferred tax liabilities | 322.05 | 411.81 | 1 086.31 | 655.17 | 580.10 |
| Other non-interest bearing current liabilities | 2 189.58 | 1 496.01 | 1 340.86 | 2 587.00 | 3 704.56 |
| Current liabilities total | 2 734.16 | 2 676.96 | 3 304.32 | 4 174.05 | 21 695.61 |
| Balance sheet total (liabilities) | 10 128.63 | 13 971.07 | 17 629.50 | 18 397.95 | 39 033.63 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.